Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prasugrel vs High-Dose Clopidogrel in Stable CAD
NCT01304472Phase 3Completed
- Sponsor
- University of Patras
- Start
- Feb 2011
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of prasugrel in coronary artery disease (CAD) (2 arms), sponsored by University of Patras. Primary endpoint: Change in Platelet Reactivity at 28 days. Started Feb 2011; status: completed.
02
Drugs
prasugrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01304472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01304472.